NightHawk Biosciences Provides 2022 Year End Business Update

DURHAM, N.C., March 31, 2023 -- NightHawk Biosciences , a fully-integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today provided... | March 31, 2023

Related Keywords

Canada , United States , San Antonio , Texas , Kansas , American , Canadian , Jeff Wolf , Company San Antonio , Twitter , Nighthawk Biosciences Inc , American Company Guidelines Sections , Hawk Biosciences , Chief Executive Officer , Nighthawk Biosciences , Company Guidelines Sections , Private Securities Litigation Reform Act , Nc Stock Exchange , News , Information , Press Release , Arch , 023 , Nighthawk , Iosciences , Iopharmaceutical , Company , Ocused , N , Developing , Therapies , O , Modulate , The , Immune , Oday Nhwk Us42237k4094 ,